A recent meta-analysis of 20 randomized, double-blind, placebo-controlled trials concluded that treatment with PCSK9 blocking antibody did not increase the risk for sepsis, nor was this related to severe bacterial and viral infections [16]. Here, PCSK9 is linked to Sepsis.